Isaac E. Ciechanover

2015

In 2015, Isaac E. Ciechanover earned a total compensation of $6.5M as President and Chief Executive Officer at Atara Biotherapeutics, a 156% increase compared to previous year.

Compensation breakdown

Bonus$419,569
Option Awards$4,658,726
Salary$506,250
Stock Awards$955,700
Other$5,286
Total$6,545,531

Ciechanover received $4.7M in option awards, accounting for 71% of the total pay in 2015.

Ciechanover also received $419.6K in bonus, $506.3K in salary, $955.7K in stock awards and $5.3K in other compensation.

Rankings

In 2015, Isaac E. Ciechanover's compensation ranked 1,094th out of 13,638 executives tracked by ExecPay. In other words, Ciechanover earned more than 92.0% of executives.

ClassificationRankingPercentile
All
1,094
out of 13,638
92nd
Division
Manufacturing
388
out of 5,187
93rd
Major group
Chemicals And Allied Products
135
out of 1,857
93rd
Industry group
Drugs
103
out of 1,531
93rd
Industry
Biological Products, Except Diagnostic Substances
16
out of 260
94th
Source: SEC filing on April 24, 2017.

Ciechanover's colleagues

We found two more compensation records of executives who worked with Isaac E. Ciechanover at Atara Biotherapeutics in 2015.

2015

Heather Turner

Atara Biotherapeutics

General Counsel

2015

Christopher Haqq

Atara Biotherapeutics

Chief Scientific Officer

News

In-depth

You may also like